Avidity Biosciences: www.aviditybio.com
Press Release: Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial Use The MOVE+ Natural History Study will focus on developing disease progression biomarkers utilizing whole-body MRI and other tools to enhance future clinical trial design for the Facioscapulohumeral Muscular Dystrophy (FSHD) community. 
View Press Release

Dyne Therapeutics: https://www.dyne-tx.com/

FSHD Canada: https://fshd.ca/

FSH Society: https://www.fshsociety.org/

Friends of FSH: http://www.fshfriends.org/

Fulcrum Therapeutics: http://www.fulcrumtx.com/

MDA: https://www.mda.org/

National Institute of Neurological Disorders and Stroke: https://www.ninds.nih.gov/